News | April 14, 2025
Novartis to invest $23 billion on expansion of manufacturing and R&D facilities in US
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial) have an estimated market size of US$ 48 million for twelve months ending December 2024 according to IQVIA
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
There are 38.4 million people with diabetes in the United States
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
